Immune Correlates and Mechanisms of Controlling NTS Bacteremia

免疫相关性和控制 NTS 菌血症的机制

基本信息

  • 批准号:
    8026709
  • 负责人:
  • 金额:
    $ 38.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-10 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

Non-typhoidal Salmonella (NTS) colonizes food animals and causes human gastroenterifis in the U.S., cosfing billions of dollars annually. NTS also causes bacteremia in immunocompromised individuals, including those with cancer or autoimmune diseases, at the extremes of age, or those taking immunosuppressive medicafions. HIV infected individuals and AIDS pafients are also at risk, and thus susceptibility to NTS bacteremia is a problem shared throughout the world. In tropical Africa, where HIV is epidemic, the populafion also suffers from malnutrition, poor water quality, and infestations with malaria and helminthes, all of which alter host immune responses and therefore suscepfibility to NTS infections. Although neither the host responses required for controlling NTS bacteremia nor the epidemiology of NTS infecfions in Africa are well studied, recent data indicates human-to-human transmission of NTS. Thus, an enlarging population of suscepfible hosts suffers NTS bacteremia and, through human-to-human transmission, exposes other hosts with immune systems variably compromised by additional infections, young age, or other insults; thereby creating a new host-pathogen 'ecosystem' in one part of the worid. This unique environment may be permissive for propagation of NTS strains with altered properties, especially in comparison with their NTS cousins from the U.S. where transmission most commonly occurs from food animal to humans. This project will test interrelated hypotheses directed toward understanding immune mechanisms controlling NTS bacteremia and the attributes of bacterial strains arising in this unique environment: 1) altered immune detecfion, relevant to colonizing and causing bacteremia in immunocompromised hosts, has arisen in NTS strains as a result of human-to-human transmission, 2) interrelated immune functions, including T and B cell, macrophage and cytokine funcfions are important for controlling bacteremia, 3) specific immune defects, relevant to our study populations, facilitate NTS colonizafion/bacteremia, and 4) examining differenfial immune recognition of NTS isolates by bacteremic patients and their close contacts will aid us in establishing screening criteria for Salmonella carrier status and provide preliminary indicators of bacterial anfigens potentially useful for vaccines protecfive against bacteremia. This project is substanfially enhanced by reagents resulting from the work described in Projects 1 and 2, provides mechanistic data to aid in the interpretation of clinical data gathered in Project 1, and provides experimental systems for further evaluating strains of interest defined in Project 2.
非细类沙门氏菌(NTS)将食用动物定居,并在美国引起人类胃肠道,每年销售数十亿美元。 NT还会引起免疫功能低下的个体(包括癌症或自身免疫性疾病的患者)的菌血症,或服用免疫抑制药物治疗的人。艾滋病毒感染的个体和艾滋病的适合素也处于危险之中,因此对NTS菌血症的易感性是全世界共有的一个问题。在艾滋病毒流行病的热带非洲,人群还遭受营养不良,水质差以及疟疾和蠕虫的侵扰,所有这些都改变了宿主的免疫反应,因此可疑对NTS感染。尽管控制NTS菌血症所需的宿主反应和非洲NTS的流行病学都没有很好地研究,但最近的数据表明,NTS的人类对人类对人类的传播。因此,扩大的可疑宿主人群患有NTS菌血症,并通过人类到人类的传播,暴露了其他免疫系统的其他宿主,这些宿主因其他感染,年轻年龄或其他侮辱而造成了可观的损害。从而在糟糕的一部分中创建一个新的宿主病原体“生态系统”。这种独特的环境可能允许使用具有改变特性的NTS菌株的繁殖,尤其是与美国的NTS堂兄相比 动物对人类。 This project will test interrelated hypotheses directed toward understanding immune mechanisms controlling NTS bacteremia and the attributes of bacterial strains arising in this unique environment: 1) altered immune detecfion, relevant to colonizing and causing bacteremia in immunocompromised hosts, has arisen in NTS strains as a result of human-to-human transmission, 2) interrelated immune functions, including T and B cell, macrophage and cytokine funcfions are important for controlling bacteremia, 3) specific immune defects, relevant to our study populations, facilitate NTS colonizafion/bacteremia, and 4) examining differenfial immune recognition of NTS isolates by bacteremic patients and their close contacts will aid us in establishing screening criteria for Salmonella carrier status and provide preliminary indicators of bacterial源源不断可用于疫苗蛋白质抗血症的疫苗。该项目由项目1和2中所述的工作产生的试剂旨在增强,并提供了机械数据,以帮助解释项目1中收集的临床数据,并提供实验系统,以进一步评估项目2中定义的感兴趣菌株。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRAD T COOKSON其他文献

BRAD T COOKSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRAD T COOKSON', 18)}}的其他基金

Caliper Life Sciences IVIS Lumina II imaging system
Caliper 生命科学 IVIS Lumina II 成像系统
  • 批准号:
    8246848
  • 财政年份:
    2012
  • 资助金额:
    $ 38.27万
  • 项目类别:
Career Development and Training Program
职业发展和培训计划
  • 批准号:
    8236995
  • 财政年份:
    2011
  • 资助金额:
    $ 38.27万
  • 项目类别:
Development Research Plan
发展研究计划
  • 批准号:
    8236993
  • 财政年份:
    2011
  • 资助金额:
    $ 38.27万
  • 项目类别:
Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes
耶尔森菌在肿块淋巴结中存活的宿主和病原体相关机制
  • 批准号:
    8236985
  • 财政年份:
    2011
  • 资助金额:
    $ 38.27万
  • 项目类别:
Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes
耶尔森菌在肿块淋巴结中存活的宿主和病原体相关机制
  • 批准号:
    7675881
  • 财政年份:
    2009
  • 资助金额:
    $ 38.27万
  • 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
  • 批准号:
    6285611
  • 财政年份:
    2001
  • 资助金额:
    $ 38.27万
  • 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
  • 批准号:
    6488760
  • 财政年份:
    2001
  • 资助金额:
    $ 38.27万
  • 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
  • 批准号:
    6691702
  • 财政年份:
    2001
  • 资助金额:
    $ 38.27万
  • 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
  • 批准号:
    6836493
  • 财政年份:
    2001
  • 资助金额:
    $ 38.27万
  • 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
  • 批准号:
    6626383
  • 财政年份:
    2001
  • 资助金额:
    $ 38.27万
  • 项目类别:

相似海外基金

Can Sexually Transmitted Pathogens Impact the Efficacy of HIV-1 Microbicides?
性传播病原体会影响 HIV-1 杀菌剂的功效吗?
  • 批准号:
    8438517
  • 财政年份:
    2013
  • 资助金额:
    $ 38.27万
  • 项目类别:
Can Sexually Transmitted Pathogens Impact the Efficacy of HIV-1 Microbicides?
性传播病原体会影响 HIV-1 杀菌剂的功效吗?
  • 批准号:
    8774176
  • 财政年份:
    2013
  • 资助金额:
    $ 38.27万
  • 项目类别:
HIV-1 Cryptic Epitopes: Implications for Vaccine Design
HIV-1 隐性表位:对疫苗设计的影响
  • 批准号:
    8131729
  • 财政年份:
    2009
  • 资助金额:
    $ 38.27万
  • 项目类别:
CC Chemokine Secretion to Protect Antigen-Specific CD4 T Cells from HIV
CC 趋化因子分泌保护抗原特异性 CD4 T 细胞免受 HIV 感染
  • 批准号:
    7761148
  • 财政年份:
    2009
  • 资助金额:
    $ 38.27万
  • 项目类别:
Induction of Mucosal Cellular Immunity by HIV-1 Vaccine Vectors
HIV-1 疫苗载体诱导粘膜细胞免疫
  • 批准号:
    7756350
  • 财政年份:
    2009
  • 资助金额:
    $ 38.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了